Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease - A Randomized Controlled Trial

Description

The Short-Cut trial is a prospective, investigator-initiated, multicenter, randomized controlled trial that is designed to compare the efficacy of cutting balloon angioplasty vs. intravascular lithotripsy prior to drug-eluting stent implantation in patients with moderate to severely calcified coronary arteries.

Conditions

Treatment in Calcified Coronary Disease

Study Overview

Study Details

Study overview

The Short-Cut trial is a prospective, investigator-initiated, multicenter, randomized controlled trial that is designed to compare the efficacy of cutting balloon angioplasty vs. intravascular lithotripsy prior to drug-eluting stent implantation in patients with moderate to severely calcified coronary arteries.

Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease - A Randomized Controlled Trial (Short-Cut)

Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease - A Randomized Controlled Trial

Condition
Treatment in Calcified Coronary Disease
Intervention / Treatment

-

Contacts and Locations

Birmingham

UAB Structural Heart and Valve Clinic, Birmingham, Alabama, United States, 35233

Phoenix

Banner Health, Phoenix, Arizona, United States, 85012

Scottsdale

Honor Health, Scottsdale, Arizona, United States, 13400

San Francisco

UCSF Cardiology, San Francisco, California, United States, 94117

New Haven

Yale School of Medicine, New Haven, Connecticut, United States, 06510

Overland Park

Saint Luke's, Overland Park, Kansas, United States, 66207

Portland

Maine Medical Center, Portland, Maine, United States, 04102

Boston

Massachusetts General Hospital, Boston, Massachusetts, United States, 02115

Boston

Beth Israel Deaconess Medcial Center, Boston, Massachusetts, United States, 02215

Detroit

Henry Ford Health, Detroit, Michigan, United States, 48202

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 1. Subject is \> 21 years old 2. Subject with an indication for PCI for the treatment of a) stable coronary artery disease; b) unstable angina; or c) NSTEMI with evidence of down-trending biomarkers 3. Subject is willing and able to provide informed written consent Angiographic Inclusion Criteria
  • 1. The target lesion is a de novo native coronary lesion
  • 2. The target vessel is a native coronary artery with either:
  • 1. A stenosis \> 70%; or,
  • 2. A stenosis \> 50% and \<70% with evidence of ischemia via either positive stress test, FFR value \< 0.80 or RFR/iFR/DFR value \< 0.89
  • 3. The reference diameter of the target vessel is \> 2.5mm and \< 4.0 mm at the lesion site
  • 4. The target lesion has evidence of significant calcium at the lesion site defined either as,
  • 1. The presence of radiopacities involving both sides of the arterial wall \> 5mm and involving the target lesion on angiography
  • 2. the presence of \> 270o arc of superficial calcium on intravascular imaging with a length \> 5mm or the presence of 360o arc of superficial calcium
  • 1. Patient is pregnant
  • 2. Patient is actively participating in another clinical trial
  • 3. Known LVEF \< 25%
  • 4. Ongoing Non-STEMI with rising biomarkers
  • 5. Cardiogenic shock or requirement for mechanical/pharmacologic hemodynamic support
  • 6. Planned use in the randomized lesion of a bare metal stent or non-stent treatment only
  • 7. Patient has a known allergy to contrast which cannot be adequately pre-treated
  • 8. Patient has a history of bleeding or coagulopathy and is unable to receive blood transfusion if needed
  • 9. Patient presents with STEMI
  • 10. Patient is unable to tolerate dual anti-platelet therapy
  • 11. Patient has suffered a recent cerebrovascular event (stroke/TIA) within last 30 days
  • 1. Presence of large thrombus in the target vessel
  • 2. Inability to pass coronary guidewire across the lesion
  • 3. The target vessel has excessive tortuosity (Defined as presence of 2+ bends \> 90o or 3+ bends \> 75o) or other anatomic considerations that precludes intravascular imaging
  • 4. The target lesion is within a coronary artery bypass graft
  • 5. The target lesion involves a bifurcation lesion in which either a 2-stent strategy is planned or both branches are planned for calcium modification
  • 6. Coronary artery disease that requires surgical revascularization
  • 7. Angiographic or imaging evidence of dissection in the target vessel prior to randomization
  • 8. Investigator feels there is not equipoise regarding the treatment strategy

Ages Eligible for Study

21 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Baim Institute for Clinical Research,

Study Record Dates

2025-12-30